Author

Kyle Finos

Weill Cornell Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

André F. RendeiroiD· 1 shared Arshdeep SinghiD· 1 shared Bevan Emma HuangiD· 1 shared Bhavneet BhinderiD· 1 shared Bradley B. PuaiD· 1 shared Hiranmayi RavichandraniD· 1 shared Junbum KimiD· 1 shared Liron YoffeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André F. RendeiroORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression

Junbum Kim, Hiranmayi Ravichandran, Liron Yoffe, Bhavneet Bhinder, Kyle Finos, Arshdeep Singh, Bradley B. Pua, Stewart Bates, Bevan Emma Huang, André F. Rendeiro, Vivek Mittal, Nasser Khaled Altorki, Timothy E. McGraw, Olivier Elemento

This study profiles early-stage lung adenocarcinoma using multiplexed imaging mass cytometry to reveal two progression pathways: inflammation-driven and fibrosis-driven, with EMT masking malignant cell expansion.

bioRxiv · Feb 19, 2025 · PreprintCancer Biology